Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

about

Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

Item

http://www.wikidata.org/entity/Q58704386

description

article

@en

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Impact of co-infection by hepa ...... erapy in HIV-positive patients

@en

Impact of co-infection by hepa ...... erapy in HIV-positive patients

@nl

type

Item

label

Impact of co-infection by hepa ...... erapy in HIV-positive patients

@en

Impact of co-infection by hepa ...... erapy in HIV-positive patients

@nl

prefLabel

Impact of co-infection by hepa ...... erapy in HIV-positive patients

@en

Impact of co-infection by hepa ...... erapy in HIV-positive patients

@nl

P1476

Impact of co-infection by hepa ...... erapy in HIV-positive patients

@en

P2093

Enrique Bernal

http://www.w3.org/2001/XMLSchema#string

Gemma Navarro

http://www.w3.org/2001/XMLSchema#string

Inmaculada Jarrín

http://www.w3.org/2001/XMLSchema#string

Jose Antonio Iribarren Loyarte

http://www.w3.org/2001/XMLSchema#string

Juan Berenguer

http://www.w3.org/2001/XMLSchema#string

Juan Gonzalez-Garcia

http://www.w3.org/2001/XMLSchema#string

Julian Alexander Portocarrero Nuñez

http://www.w3.org/2001/XMLSchema#string

Luis Metola

http://www.w3.org/2001/XMLSchema#string

María Jesús Vivancos Gallego

http://www.w3.org/2001/XMLSchema#string

P2860

Virological Mechanisms in the Coinfection between HIV and HCV

High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin trea

Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.

The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1/2-dependent upregulation of TNF-α and IL-6.

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.

Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells

HIV/hepatitis C coinfection natural history and disease progression.

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received

P304

e12238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000012238

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Julia del Amo

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30235668

http://www.w3.org/2001/XMLSchema#string

P921

immunology

P932

6160110

http://www.w3.org/2001/XMLSchema#string